September 30, 2025 · Form 4 insider transaction
Scadden David bought 200 shares of Agios Pharmaceuticals, Inc. at $18.09 per share, a transaction worth $3.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.